Nicola Heffron

Patrimonio netto: 106 643 $ in data 31/05/2024

52 anni

Health Technology

Consumer Services

Posizioni attive di Nicola Heffron

Società	Posizione	Inizio	Fine
ALEXION PHARMACEUTICALS, INC.	Vendite & Marketing	01/04/2023	-

Società	Posizione	Inizio	Fine
2SEVENTY BIO, INC.	Direttore operativo	04/11/2021	10/03/2023
CELGENE	Vendite & Marketing	01/05/2018	01/09/2018
BLUEBIRD BIO, INC.	Corporate Officer/Principal	01/01/2020	-

University of Warwick

Masters Business Admin

Distribuzione geografica

Stati Uniti	5
Regno Unito	2

Posizioni

Sales & Marketing	2
Corporate Officer/Principal	1
Masters Business Admin	1

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
BLUEBIRD BIO, INC.	Health Technology
2SEVENTY BIO, INC.	Health Technology

Aziende private	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology

Aziende private

Health Technology